YOSHIO YAMAOKA to Pepsinogen A
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Pepsinogen A.
Connection Strength
2.111
-
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. PLoS One. 2020; 15(4):e0230064.
Score: 0.653
-
Helicobacter pylori Infection and Gastric Mucosal Atrophy in Two Ethnic Groups in Nepal. Asian Pac J Cancer Prev. 2015; 16(17):7911-6.
Score: 0.453
-
Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Biomark Med. 2014; 8(9):1127-37.
Score: 0.423
-
Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during Helicobacter pylori Infection. Gut Liver. 2024 01 15; 18(1):60-69.
Score: 0.207
-
Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence. PLoS One. 2018; 13(11):e0205644.
Score: 0.148
-
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol. 2014 Jan; 29(1):67-73.
Score: 0.106
-
Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol. 2013 Oct; 62(Pt 10):1571-1578.
Score: 0.102
-
Clinical relevance of cagPAI intactness in Helicobacter pylori isolates from Vietnam. Eur J Clin Microbiol Infect Dis. 2010 Jun; 29(6):651-60.
Score: 0.020